Considering the fact that K-Ras is mutated in ~95 % cases of pancreatic tumors, PAK4 might also be involved in mediating and/or regulating constitutive K-Ras activation-driven downstream signaling pathways involved in cell proliferation, survival and therapy resistance [28, 29]. Here, PAK4 is linked to pancreatic neoplasm.